Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,328 GBX | -1.82% | -0.56% | +16.30% |
12:39pm | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
Jun. 26 | European Equities Close Lower in Wednesday Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.30% | 246B | |
+55.24% | 811B | |
+43.62% | 640B | |
-7.09% | 353B | |
+18.00% | 333B | |
+8.76% | 302B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.38% | 168B | |
-3.42% | 155B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Tagrisso Reduces Lung Cancer Progression in Phase 3 Trial